Company intelligence / Profile preview

Ranvier Research, Inc.

Bristol, England, United Kingdomurmc.rochester.edu ↗

Ownership: Private
Development stage: Preclinical

Overview

Ranvier Health Ltd sponsors a clinical study using a taste test device to serve as a surrogate biomarker predicting antidepressant effectiveness in patients with depression. The study aims to correlate taste test results with validated mood questionnaires before and after antidepressant treatment. No published clinical results yet.[3]

Therapeutic areas: Psychiatry
Modalities: Diagnostic devices/biomarkers (taste test device for depression diagnosis)[3]
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Ranvier Research, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ranvier Research, Inc..

Explore the full profile